Status: Recruiting
A Study of Ranolazine in ALS
The purpose of this study is to evaluate safety, effect on cramps, function and quality of life of ranolazine versus placebo for the treatment of ALS.
Participants needed: 72
Trial details
Phase: Phase 2Age: 18+Biological sex: AllType: InterventionalSponsor: Swathy Chandrashekhar, MBBSUpdated: Jun 8, 2026Locations: 6
Eligibility criteria
18 years or older [+5]
Disease duration < 5 years [+7]